Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Bradley Dixon

Concepts (257)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glomerulonephritis, Membranoproliferative
6
2026
29
2.710
Why?
Complement C3
5
2026
195
2.210
Why?
Atypical Hemolytic Uremic Syndrome
8
2024
23
2.130
Why?
Kidney Diseases
6
2025
428
1.190
Why?
Thrombotic Microangiopathies
6
2020
19
1.060
Why?
Immune Complex Diseases
1
2026
6
0.960
Why?
Antigen-Antibody Complex
1
2026
70
0.940
Why?
Renal Insufficiency, Chronic
6
2026
640
0.810
Why?
Complement Inactivating Agents
5
2026
78
0.720
Why?
Kidney
11
2026
1498
0.700
Why?
Antibodies, Monoclonal, Humanized
9
2024
992
0.680
Why?
Tuberous Sclerosis
4
2017
56
0.620
Why?
TRPM Cation Channels
2
2019
74
0.610
Why?
Proteinuria
5
2026
103
0.600
Why?
Hypertension
5
2026
1272
0.590
Why?
Hemolytic-Uremic Syndrome
1
2019
15
0.570
Why?
Nephrotic Syndrome
3
2025
44
0.570
Why?
Hematopoietic Stem Cell Transplantation
5
2019
704
0.570
Why?
Lupus Nephritis
3
2025
67
0.570
Why?
Complement System Proteins
5
2025
326
0.520
Why?
Antihypertensive Agents
3
2026
519
0.520
Why?
Acute Kidney Injury
5
2025
866
0.520
Why?
Osmoregulation
1
2017
4
0.500
Why?
DNA Damage
2
2011
439
0.500
Why?
Kidney Tubules, Collecting
1
2017
25
0.500
Why?
Osmotic Pressure
1
2017
41
0.500
Why?
Immunosuppressive Agents
6
2025
829
0.480
Why?
Kidney Transplantation
5
2026
735
0.440
Why?
Autoimmunity
1
2020
925
0.410
Why?
Peptides, Cyclic
2
2026
276
0.410
Why?
Autoantibodies
2
2020
1500
0.390
Why?
Child
26
2026
22693
0.340
Why?
Epithelial Cells
2
2019
1119
0.340
Why?
Cell Line
3
2019
2814
0.330
Why?
Urothelium
1
2011
33
0.330
Why?
Angiotensin Receptor Antagonists
2
2026
115
0.320
Why?
Renal Dialysis
3
2026
461
0.320
Why?
Adolescent
18
2026
22557
0.310
Why?
Humans
48
2026
146342
0.310
Why?
Osmolar Concentration
1
2009
165
0.290
Why?
Glomerular Filtration Rate
4
2026
745
0.280
Why?
Pyrimidines
3
2022
532
0.280
Why?
RecQ Helicases
1
2008
9
0.280
Why?
Angiomyolipoma
3
2014
21
0.280
Why?
Cell Cycle
1
2011
595
0.260
Why?
Biopsy
3
2026
1075
0.260
Why?
Complement Activation
3
2025
412
0.250
Why?
Purines
1
2008
188
0.250
Why?
Urinary Bladder
1
2009
194
0.250
Why?
Child, Preschool
12
2026
11913
0.250
Why?
Treatment Outcome
11
2026
11821
0.240
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2026
228
0.240
Why?
Escherichia coli Proteins
1
2008
200
0.240
Why?
Benzoates
1
2026
48
0.240
Why?
Risk Factors
6
2026
10921
0.230
Why?
Nephrology
2
2024
59
0.230
Why?
Induction Chemotherapy
1
2025
87
0.220
Why?
Prenatal Injuries
1
2005
1
0.220
Why?
Hypertension, Renal
1
2005
15
0.220
Why?
Calcium Channel Blockers
1
2026
165
0.220
Why?
Retroperitoneal Space
1
2005
19
0.220
Why?
Nephrocalcinosis
1
2024
12
0.210
Why?
Familial Hypophosphatemic Rickets
1
2024
6
0.210
Why?
Hematoma
1
2005
62
0.210
Why?
Male
22
2026
73396
0.210
Why?
Piperidines
1
2026
225
0.210
Why?
Kidney Diseases, Cystic
2
2017
24
0.210
Why?
Rituximab
1
2025
208
0.210
Why?
Glomerulosclerosis, Focal Segmental
1
2024
43
0.200
Why?
Female
23
2026
79499
0.200
Why?
Polycystic Kidney Diseases
1
2005
82
0.200
Why?
Cost of Illness
1
2026
323
0.200
Why?
Kidney Neoplasms
3
2014
419
0.200
Why?
Lymphohistiocytosis, Hemophagocytic
2
2017
33
0.200
Why?
Disease Management
2
2020
651
0.200
Why?
Nephritis
1
2023
22
0.190
Why?
Disease Progression
3
2026
2867
0.190
Why?
Slipped Capital Femoral Epiphyses
1
2022
10
0.190
Why?
Femur Head Necrosis
1
2022
17
0.180
Why?
Delphi Technique
1
2024
350
0.180
Why?
Algorithms
3
2026
1849
0.180
Why?
Terminology as Topic
1
2024
253
0.180
Why?
Complement Factor B
1
2023
106
0.180
Why?
Self-Management
1
2025
207
0.180
Why?
Indoles
1
2026
511
0.180
Why?
Pharmacists
1
2025
260
0.180
Why?
Arthritis, Juvenile
1
2022
64
0.180
Why?
Wounds, Nonpenetrating
1
2005
305
0.170
Why?
DNA
1
2008
1421
0.170
Why?
Rheumatology
1
2022
136
0.160
Why?
Recurrence
1
2024
1133
0.160
Why?
Phenotype
2
2026
3206
0.150
Why?
Glomerulonephritis
1
2019
46
0.150
Why?
Tumor Suppressor Proteins
2
2012
315
0.140
Why?
Plasma Exchange
1
2019
18
0.140
Why?
Cilia
2
2019
171
0.140
Why?
Lupus Erythematosus, Systemic
1
2021
241
0.140
Why?
Mice, Transgenic
2
2017
2134
0.140
Why?
Hirschsprung Disease
1
2020
93
0.140
Why?
Disease Susceptibility
1
2020
339
0.140
Why?
TRPP Cation Channels
1
2019
76
0.140
Why?
Plasmapheresis
1
2018
24
0.140
Why?
Critical Illness
2
2023
908
0.140
Why?
Electronic Health Records
3
2023
1210
0.140
Why?
Escherichia coli Infections
1
2019
125
0.130
Why?
Renal Replacement Therapy
1
2019
102
0.130
Why?
Sirolimus
2
2017
282
0.130
Why?
Creatinine
3
2026
511
0.130
Why?
Fluid Therapy
1
2019
154
0.130
Why?
Blood Component Transfusion
1
2018
99
0.130
Why?
Hydroxyprostaglandin Dehydrogenases
1
2017
3
0.130
Why?
GABA Plasma Membrane Transport Proteins
1
2017
7
0.130
Why?
Caregivers
2
2026
1080
0.130
Why?
Transfection
2
2017
916
0.120
Why?
Saline Solution, Hypertonic
1
2017
43
0.120
Why?
TRPV Cation Channels
1
2017
43
0.120
Why?
Erythrocyte Transfusion
1
2019
226
0.120
Why?
Quality of Life
2
2026
3200
0.120
Why?
Plasma
1
2018
222
0.120
Why?
Time Factors
2
2026
7109
0.120
Why?
Autoimmune Diseases
1
2020
467
0.120
Why?
Streptococcal Infections
1
2019
179
0.120
Why?
Gene Editing
1
2017
89
0.110
Why?
Infant
7
2025
10114
0.110
Why?
Patient Selection
1
2019
728
0.110
Why?
CRISPR-Cas Systems
1
2017
163
0.110
Why?
Cytomegalovirus Infections
1
2017
206
0.110
Why?
Young Adult
7
2026
14330
0.110
Why?
Diagnosis, Differential
1
2019
1503
0.100
Why?
Transplantation Conditioning
1
2015
193
0.100
Why?
Pericytes
1
2014
42
0.100
Why?
Complement Membrane Attack Complex
1
2013
38
0.100
Why?
Retrospective Studies
7
2025
17438
0.100
Why?
Adult
7
2026
41087
0.100
Why?
Complement Factor D
2
2022
28
0.090
Why?
Transplantation, Autologous
2
2013
306
0.090
Why?
Complement Pathway, Alternative
1
2013
123
0.090
Why?
Indazoles
2
2022
86
0.090
Why?
Proline
2
2022
79
0.090
Why?
Aminopyridines
2
2022
128
0.090
Why?
Hematologic Neoplasms
1
2013
170
0.090
Why?
Endoplasmic Reticulum Stress
1
2012
120
0.080
Why?
Antigens, Polyomavirus Transforming
1
2011
15
0.080
Why?
Biomarkers
4
2025
4340
0.080
Why?
Nephrolithiasis
1
2010
10
0.080
Why?
Double-Blind Method
2
2026
2070
0.080
Why?
Histoplasmosis
1
2010
15
0.080
Why?
Prognosis
1
2019
4351
0.080
Why?
Mice
3
2019
18297
0.070
Why?
DNA Breaks, Double-Stranded
1
2009
55
0.070
Why?
Organ Specificity
1
2009
307
0.070
Why?
Kanamycin Resistance
1
2008
2
0.070
Why?
Cell Line, Tumor
3
2014
3545
0.070
Why?
Viral Regulatory and Accessory Proteins
1
2008
27
0.070
Why?
Prospective Studies
4
2023
8123
0.070
Why?
Mutation
2
2010
4093
0.070
Why?
Endothelium, Vascular
1
2014
952
0.070
Why?
Renal Insufficiency
1
2010
173
0.070
Why?
Urinary Bladder Neoplasms
1
2011
259
0.070
Why?
Incidence
1
2014
2936
0.060
Why?
Stomach Neoplasms
1
2009
128
0.060
Why?
Blood Pressure
2
2025
1765
0.060
Why?
United States
4
2025
16136
0.060
Why?
Stress, Mechanical
1
2009
497
0.060
Why?
Plasmids
1
2008
373
0.060
Why?
Colonic Neoplasms
1
2009
259
0.060
Why?
DNA Repair
1
2009
255
0.060
Why?
DNA, Bacterial
1
2008
319
0.060
Why?
DNA Replication
1
2008
248
0.060
Why?
Signal Transduction
2
2017
5246
0.060
Why?
Blotting, Western
1
2008
1177
0.060
Why?
Mice, Inbred C57BL
1
2017
6034
0.060
Why?
Antigens, CD20
1
2025
34
0.060
Why?
Mycophenolic Acid
1
2025
117
0.050
Why?
Clinical Trials, Phase III as Topic
1
2025
116
0.050
Why?
Cyclophosphamide
1
2025
275
0.050
Why?
Kidney Glomerulus
1
2025
129
0.050
Why?
Nucleic Acid Conformation
1
2008
724
0.050
Why?
Comparative Effectiveness Research
1
2026
171
0.050
Why?
Repressor Proteins
1
2008
430
0.050
Why?
Apoptosis
2
2012
2439
0.050
Why?
Escherichia coli
1
2008
832
0.050
Why?
Animals
3
2019
38107
0.050
Why?
Remission Induction
1
2024
308
0.050
Why?
Adrenal Cortex Hormones
1
2025
486
0.050
Why?
Consensus
1
2024
467
0.050
Why?
Middle Aged
4
2025
36619
0.040
Why?
Atrophy
1
2022
199
0.040
Why?
Immunoglobulin A
1
2023
205
0.040
Why?
Graft Survival
1
2024
523
0.040
Why?
Complement C5
1
2020
33
0.040
Why?
Predictive Value of Tests
1
2025
2113
0.040
Why?
Radiography
1
2022
861
0.040
Why?
Fibrosis
1
2022
568
0.040
Why?
Forms and Records Control
1
2019
21
0.040
Why?
Information Services
1
2019
42
0.040
Why?
Pregnenolone
1
2019
3
0.040
Why?
Gelatinases
1
2019
6
0.040
Why?
Observational Studies as Topic
1
2019
133
0.040
Why?
Fibrinogen
1
2020
182
0.040
Why?
Area Under Curve
1
2019
335
0.040
Why?
Cystatin C
1
2019
65
0.040
Why?
Single-Blind Method
1
2019
313
0.040
Why?
Magnetic Resonance Imaging
2
2017
3926
0.040
Why?
International Classification of Diseases
1
2019
142
0.040
Why?
Gene Knockout Techniques
1
2019
122
0.030
Why?
Flavonoids
1
2019
85
0.030
Why?
Randomized Controlled Trials as Topic
1
2025
1763
0.030
Why?
Severity of Illness Index
2
2019
2921
0.030
Why?
Allografts
1
2019
151
0.030
Why?
ROC Curve
1
2019
617
0.030
Why?
Calcium Signaling
1
2019
246
0.030
Why?
Kidney Function Tests
1
2017
156
0.030
Why?
Longitudinal Studies
1
2024
3017
0.030
Why?
Hospitals, Pediatric
1
2019
561
0.030
Why?
Metabolic Clearance Rate
1
2015
115
0.030
Why?
Intensive Care Units
1
2021
925
0.030
Why?
Receptor, Angiotensin, Type 1
1
2014
25
0.030
Why?
Valsartan
1
2014
33
0.030
Why?
Complement Hemolytic Activity Assay
1
2013
2
0.030
Why?
Tetrazoles
1
2014
50
0.030
Why?
Valine
1
2014
84
0.030
Why?
Drug Dosage Calculations
1
2013
27
0.030
Why?
Renin-Angiotensin System
1
2014
80
0.020
Why?
Angiotensin II
1
2014
102
0.020
Why?
Surveys and Questionnaires
1
2026
6073
0.020
Why?
Veterans
1
2025
1650
0.020
Why?
Leupeptins
1
2012
13
0.020
Why?
Transplantation, Homologous
1
2013
416
0.020
Why?
In Vitro Techniques
1
2014
1041
0.020
Why?
Proteasome Inhibitors
1
2012
42
0.020
Why?
Eukaryotic Initiation Factor-2
1
2012
34
0.020
Why?
Transcription Factor CHOP
1
2012
32
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2012
88
0.020
Why?
Cross-Sectional Studies
1
2023
5899
0.020
Why?
Everolimus
1
2012
112
0.020
Why?
Pregnancy
1
2005
7230
0.020
Why?
Gene Deletion
1
2013
385
0.020
Why?
Drug Administration Schedule
1
2013
790
0.020
Why?
Cohort Studies
1
2022
6077
0.020
Why?
Mechanistic Target of Rapamycin Complex 1
1
2012
141
0.020
Why?
Caspase 3
1
2012
240
0.020
Why?
Multiprotein Complexes
1
2012
168
0.020
Why?
Survival Analysis
1
2013
1378
0.020
Why?
Drug Monitoring
1
2013
399
0.020
Why?
False Negative Reactions
1
2010
61
0.020
Why?
Obesity
1
2023
3131
0.020
Why?
Antifungal Agents
1
2010
153
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
455
0.020
Why?
Infant, Newborn
1
2020
6460
0.020
Why?
Genotype
1
2013
1879
0.020
Why?
Calcium
1
2014
1181
0.020
Why?
Phosphorylation
1
2012
1724
0.020
Why?
Cell Proliferation
1
2014
2502
0.020
Why?
Proteins
1
2012
1022
0.010
Why?
Aged
1
2025
26432
0.010
Why?
Antineoplastic Agents
1
2012
2219
0.010
Why?
Dixon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)